Background: It is well known that the sleeping position influences the rate of apnea-hypopnea events; however, whether events in one position may have more influence on daytime sleepiness than events in another position has not been thoroughly investigated. Objectives: We retrospectively examined the relationship between the body position-specific apnea-hypopnea index (AHI) and daily sleepiness. Methods: We assessed the sleeping body position, the body position-specific AHI and the Epworth Sleepiness Scale (ESS) in a total of 699 patients who were referred for suspected obstructive sleep apnea-hypopnea syndrome (OSAHS) and underwent diagnostic polysomnography. Results: For all subjects, only the lateral position-specific AHI (L-AHI) showed a weak but significant correlation with the ESS (r = 0.102; p < 0.05). For mild-to-moderate OSAHS patients, there was no correlation between the ESS and the AHI at any position. For severe OSAHS patients, the ESS showed a closer correlation with the L-AHI (r = 0.266; p < 0.001) than with the supine position-specific AHI (S-AHI; r = 0.141; p < 0.05). In a subgroup analysis, divided into positional and non-positional severe OSAHS patients, the correlation coefficients also identified a link between the L-AHI and the ESS. Finally, a multiple linear regression analysis indicated that the ESS was better explained by the L-AHI than by the S-AHI in severe OSAHS patients. Conclusion: The L-AHI is considered to have a stronger influence on daytime sleepiness than the S-AHI in Japanese patients with severe OSAHS.

Keywords:
Sleep-disordered breathing, Sleepiness, Sleeping position, Apnea-hypopnea index
1.
George CF, Smiley A: Sleep apnea and automobile crashes. Sleep 1999;22:790–795.
2.
Melamed S, Oksenberg A: Excessive daytime sleepiness and risk of occupational injuries in non-shift daytime workers. Sleep 2002;25:315–322.
3.
Chervin RD, Aldrich MS: The relation between multiple sleep latency test findings and the frequency of apnetic events in REM and non-REM sleep. Chest 1998;113:980–984.
4.
Kass JE, Akers SM, Bartter TC, Pratter MR: Rapid-eye-movement-specific sleep-disordered breathing: a possible cause of excessive daytime sleepiness. Am J Respir Crit Care Med 1996;154:167–169.
5.
Punjabi NM, Bandeen-Roche K, Marx JJ, Neubauer DN, Smith PL, Schwartz AR: The association between daytime sleepiness and sleep-disordered breathing in NREM and REM sleep. Sleep 2002;25:307–314.
6.
Chervin RD, Aldrich MS: Characteristics of apneas and hypopneas during sleep and relation to excessive daytime sleepiness. Sleep 1998;21:799–806.
7.
Pelin Z, Karadeniz D, Öztürk L, Gözükirmizi E, Kaynak H: The role of mean inspiratory effort on daytime sleepiness. Eur Respir J 2003;21:688–694.
8.
Goncalves MA, Paiva T, Ramos E, Guilleminault C: Obstructive sleep apnea syndrome, sleepiness, and quality of life. Chest 2004;125:2091–2096.
9.
Chervin RD, Aldrich MS: The Epworth Sleepiness Scale may not reflect objective measures of sleepiness or sleep apnea. Neurology 1999;52:125–131.
10.
Cung KF: Use of the Epworth Sleepiness Scale in Chinese patients with obstructive sleep apnea and normal hospital employees. J Psychosom Res 2000;49:367–372.
11.
Gülbay BE, Acican T, Onen ZP, Yildiz OA, Baccioglu A, Arslan F, Köse K: Health-related quality of life in patients with sleep-related breathing disorders: relationship with nocturnal parameters, daytime symptoms and comorbid diseases. Respiration 2008;75:393–401.
12.
Cao J, Que C, Wang G, He B: Effect of posture on airway resistance in obstructive sleep apnea-hypopnea syndrome by means of impulse oscillation. Respiration 2009;77:38–43.
13.
Oksenberg A, Silverberg DS: The effect of body posture on sleep-related breathing disorders: facts and therapeutic implications. Sleep Med Rev 1998;2:139–162.
14.
Jokic R, Klimaszewski A, Crossley M, Sridhar G, Fitzpatrick MF: Positional treatment vs continuous positive airway pressure in patients with positional obstructive sleep apnea syndrome. Chest 1999;115:771–781.
15.
Oksenberg A, Silverberg DS, Arons E, Radwan H: Positional vs nonpositional obstructive sleep apnea patients: anthropomorphic nocturnal polysomnographic, and multiple sleep latency test data. Chest 1997;112:629–639.
16.
John MW: A new method for measuring daytime sleepiness: the Epworth Sleepiness Scale. Sleep 1991;14:540–545.
17.
John MW: Reliability and factor analysis of the Epworth Sleepiness Scale. Sleep 1992;15:376–381.
18.
Rechtschaffen A, Kales A: A Manual of Standardized Terminology, Techniques and Scoring System for Sleep Stages of Human Subjects. Los Angeles, BIS/BRI, UCLA, 1968.
19.
Clinical Practice Review Committee: Hypopnea in sleep-disordered breathing in adults. Sleep 2001;24:469–470.
20.
Cartwright RD: Effect of sleep position on sleep apnea severity. Sleep 1984;7:110–114.
21.
Metersky ML, Castriotta RJ: The effect of polysomnography on sleep position: possible implications on the diagnosis of positional obstructive sleep apnea. Respiration 1996;63:283–287.
22.
Mediano O, Barcelió A, de la Peña M, Gozal D, Agustí A, Barbé F: Daytime sleepiness and polysomnographic variables in sleep apnoea patients. Eur Respir J 2007;30:110–113.
23.
Chin K, Fukuhara S, Takahaashi K, Sumi K, Nakamura T, Matsumoto H, Niimi A, Hattori N, Mishima M, Nakamura T: Response shift in perception of sleepiness in obstructive sleep apnea-hypopnea syndrome before and after treatment with nasal CPAP. Sleep 2004;27:490–493.
© 2009 S. Karger AG, Basel
2009
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.